previous compound ID: 1469 next compound
InChIKey: NGFMICBWJRZIBI-UJPOAAIJSA-N
SMILES: C1=CC=C(C(=C1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "DY Thomas" "SD Macknight" "E Matthes" "J Goepp" "R Robert" "J Liao" "D Rotin" "JW Hanrahan" "GW Carlile"

chemical graph of compound 1469





CID is 439503
synonyms found at PubChem are:
salicin, 138-52-3, Salicoside, Salicine, Salicyl alcohol glucoside, D-(-)-Salicin, (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)tetrahydro-2H-pyran-3,4,5-triol, Saligenin beta-D-glucopyranoside, 2-(Hydroxymethyl)phenyl beta-D-glucopyranoside, D-Salicin, Saligenin-beta-D-glucopyranoside, Salicin (6CI,8CI), D(-)-Salicin, 2-(Hydroxymethyl)phenyl-beta-d-glucopyranoside, o-(Hydroxymethyl)phenyl beta-D-glucopyranoside, Benzyl alcohol, o-hydroxy-, o-glucoside, UNII-4649620TBZ, AI3-19099, alpha-Hydroxy-o-tolyl beta-D-glucopyranoside, NSC 5751, EINECS 205-331-6, SPECTRUM1502255, B-D-Glucopyranoside, 2-(hydroxymethyl)phenyl, CHEBI:17814, beta-D-Glucopyranoside, 2-(hydroxymethyl)phenyl, D-()-Salicin, 4649620TBZ, SDCCGMLS-0066698.P001, NCGC00142605-01, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol, (2S,4S,5S,3R,6R)-6-(hydroxymethyl)-2-[2-(hydroxymethyl)phenoxy]-2H-3,4,5,6-tet rahydropyran-3,4,5-triol, SMR000112301, Salicin [USP], SR-05000001594, delta-Salicin, Spectrum_001230, Spectrum2_000756, Spectrum3_000948, Spectrum4_001058, Spectrum5_000971, bmse000315, D06BQU, Salicin from Plant Extract, Salicyl alcohol-b-glucoside, SCHEMBL24936, KBioGR_001356, KBioSS_001710, Saligenin-b-D-glucopyranoside, KSC914S4F, MLS000563050, MLS001306490, DivK1c_000030, S0625_SIGMA, SPBio_000772, AC1L97H8, CHEMBL462997, MEGxp0_000685, Salicin (Salicoside, Salicine), ACon1_000373, CTK8B4942, HMS500B12, KBio1_000030, KBio2_001710, KBio2_004278, KBio2_006846, KBio3_002016, BIK9020, MolPort-000-701-569, NGFMICBWJRZIBI-UJPOAAIJSA-N, NINDS_000030, HMS1921P08, HMS2092F14, HMS2268J11, Pharmakon1600-01502255, EBD45938, HY-N0149, Saligenin beta-delta-glucopyranoside, Saligenin-beta-delta-glucopyranoside, ZINC3847505, D-(-)-Salicin, analytical standard, Salicoside, Salicine, 138-52-3, ANW-46774, CCG-40332, CS0013, MFCD00006590, NSC758201, s2351, SBB012498, ZINC03847505, AKOS004907439, AC-8042, API0004125, CS-8027, D-(-)-Salicin, >=99% (GC), MCULE-4540152608, MCULE-8469382160, NSC-758201, RTR-031159, IDI1_000030, NCGC00142605-02, NCGC00142605-04, AJ-45866, AK-58886, CJ-10812, LS-71545, SC-11370, ST069327, SBI-0051746.P002, AX8002670, ST2414222, 2(hydroxymethyl)phenyl-beta-D-glucopyranoside, FT-0603347, N1880, S0003, A-8126, C01451, 2-(Hydroxymethyl)-phenyl-beta-D-glucopyranoside, 2-(hydroxymethyl)phenyl-O-beta-D-glucopyranoside, AB00052296_07, beta-D-Glucopyranoside, 2-(hydroxymethyl)phenyl-, 138S523, SR-05000001594-1, SR-05000001594-2, BRD-K64614248-001-02-4, BRD-K64614248-001-06-5, EAD32BE1-198E-432C-9F44-DC0DC9A3305B, Salicin, European Pharmacopoeia (EP) Reference Standard, (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)-phenoxy)tetrahydro-2H-pyran-3,4,5-triol, 30370-90-2, SA0